Targeting stromal microenvironment in pancreatic ductal adenocarcinoma

Controversies and promises

Lin Mei, Wei Du, Wen Wee Ma

Research output: Contribution to journalReview article

23 Citations (Scopus)

Abstract

Pancreatic cancer is a highly lethal disease. Conventional therapeutics targeting pancreas cancer cell compartment using cytotoxics improved patient survival but at the expense of significant toxicity. Microscopically, the tumor is characterized by thick desmoplastic stroma that surrounds islands of pancreatic cancer cells. The tumor microenvironment has been found to play important roles in carcinogenesis, the development of drug resistance, and mediating immunosuppression. The understanding the tumor-stromal interaction has led to the development of novel therapeutic approaches. Here, we review the strategies that are currently in (or, near to) clinical evaluation and the underlying preclinical rationales.

Original languageEnglish (US)
Pages (from-to)487-494
Number of pages8
JournalJournal of Gastrointestinal Oncology
Volume7
Issue number3
DOIs
StatePublished - Jun 1 2016
Externally publishedYes

Fingerprint

Pancreatic Neoplasms
Adenocarcinoma
Tumor Microenvironment
Drug Resistance
Islands
Immunosuppression
Neoplasms
Carcinogenesis
Survival
Therapeutics

Keywords

  • Cancer-associated fibroblast (CAF)
  • Clinical trials
  • Pancreatic adenocarcinoma
  • Pancreatic cancer
  • Stroma

ASJC Scopus subject areas

  • Oncology
  • Gastroenterology

Cite this

Targeting stromal microenvironment in pancreatic ductal adenocarcinoma : Controversies and promises. / Mei, Lin; Du, Wei; Ma, Wen Wee.

In: Journal of Gastrointestinal Oncology, Vol. 7, No. 3, 01.06.2016, p. 487-494.

Research output: Contribution to journalReview article

@article{4fc04b8cc1f04bfbac45f485ec913027,
title = "Targeting stromal microenvironment in pancreatic ductal adenocarcinoma: Controversies and promises",
abstract = "Pancreatic cancer is a highly lethal disease. Conventional therapeutics targeting pancreas cancer cell compartment using cytotoxics improved patient survival but at the expense of significant toxicity. Microscopically, the tumor is characterized by thick desmoplastic stroma that surrounds islands of pancreatic cancer cells. The tumor microenvironment has been found to play important roles in carcinogenesis, the development of drug resistance, and mediating immunosuppression. The understanding the tumor-stromal interaction has led to the development of novel therapeutic approaches. Here, we review the strategies that are currently in (or, near to) clinical evaluation and the underlying preclinical rationales.",
keywords = "Cancer-associated fibroblast (CAF), Clinical trials, Pancreatic adenocarcinoma, Pancreatic cancer, Stroma",
author = "Lin Mei and Wei Du and Ma, {Wen Wee}",
year = "2016",
month = "6",
day = "1",
doi = "10.21037/jgo.2016.03.03",
language = "English (US)",
volume = "7",
pages = "487--494",
journal = "Journal of Gastrointestinal Oncology",
issn = "2078-6891",
publisher = "Pioneer Bioscience Publishing Company (PBPC)",
number = "3",

}

TY - JOUR

T1 - Targeting stromal microenvironment in pancreatic ductal adenocarcinoma

T2 - Controversies and promises

AU - Mei, Lin

AU - Du, Wei

AU - Ma, Wen Wee

PY - 2016/6/1

Y1 - 2016/6/1

N2 - Pancreatic cancer is a highly lethal disease. Conventional therapeutics targeting pancreas cancer cell compartment using cytotoxics improved patient survival but at the expense of significant toxicity. Microscopically, the tumor is characterized by thick desmoplastic stroma that surrounds islands of pancreatic cancer cells. The tumor microenvironment has been found to play important roles in carcinogenesis, the development of drug resistance, and mediating immunosuppression. The understanding the tumor-stromal interaction has led to the development of novel therapeutic approaches. Here, we review the strategies that are currently in (or, near to) clinical evaluation and the underlying preclinical rationales.

AB - Pancreatic cancer is a highly lethal disease. Conventional therapeutics targeting pancreas cancer cell compartment using cytotoxics improved patient survival but at the expense of significant toxicity. Microscopically, the tumor is characterized by thick desmoplastic stroma that surrounds islands of pancreatic cancer cells. The tumor microenvironment has been found to play important roles in carcinogenesis, the development of drug resistance, and mediating immunosuppression. The understanding the tumor-stromal interaction has led to the development of novel therapeutic approaches. Here, we review the strategies that are currently in (or, near to) clinical evaluation and the underlying preclinical rationales.

KW - Cancer-associated fibroblast (CAF)

KW - Clinical trials

KW - Pancreatic adenocarcinoma

KW - Pancreatic cancer

KW - Stroma

UR - http://www.scopus.com/inward/record.url?scp=84995770312&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84995770312&partnerID=8YFLogxK

U2 - 10.21037/jgo.2016.03.03

DO - 10.21037/jgo.2016.03.03

M3 - Review article

VL - 7

SP - 487

EP - 494

JO - Journal of Gastrointestinal Oncology

JF - Journal of Gastrointestinal Oncology

SN - 2078-6891

IS - 3

ER -